Swiss National Bank Has $7,187,000 Position in HealthSouth Corporation (HLS)
Swiss National Bank held its position in shares of HealthSouth Corporation (NYSE:HLS) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,500 shares of the company’s stock at the end of the 2nd quarter. Swiss National Bank owned about 0.15% of HealthSouth Corporation worth $7,187,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of the business. Eagle Asset Management Inc. increased its stake in HealthSouth Corporation by 17.4% during the second quarter. Eagle Asset Management Inc. now owns 1,102,063 shares of the company’s stock worth $53,339,000 after acquiring an additional 163,116 shares during the last quarter. Principal Financial Group Inc. increased its stake in HealthSouth Corporation by 10.1% during the second quarter. Principal Financial Group Inc. now owns 1,147,210 shares of the company’s stock worth $55,524,000 after acquiring an additional 105,681 shares during the last quarter. Renaissance Group LLC increased its stake in HealthSouth Corporation by 1.9% during the second quarter. Renaissance Group LLC now owns 8,288 shares of the company’s stock worth $401,000 after acquiring an additional 152 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in HealthSouth Corporation by 161.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,075 shares of the company’s stock worth $391,000 after acquiring an additional 4,992 shares during the last quarter. Finally, Brookstone Capital Management acquired a new stake in HealthSouth Corporation during the second quarter worth $293,000. 93.10% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Swiss National Bank Has $7,187,000 Position in HealthSouth Corporation (HLS)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/16/swiss-national-bank-has-7187000-position-in-healthsouth-corporation-hls.html.
In other news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now directly owns 283,134 shares in the company, valued at approximately $12,174,762. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 1.60% of the company’s stock.
HealthSouth Corporation (NYSE HLS) opened at 44.94 on Friday. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of 15.82 and a beta of 0.59. The stock’s 50 day moving average price is $44.19 and its 200 day moving average price is $44.89. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71.
HealthSouth Corporation (NYSE:HLS) last released its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping analysts’ consensus estimates of $0.68 by $0.03. The business had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The business’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.69 EPS. On average, analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Monday, October 2nd will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.23%. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio is presently 35.29%.
Several equities research analysts have issued reports on the company. ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Stephens assumed coverage on HealthSouth Corporation in a research note on Thursday, August 31st. They set an “overweight” rating and a $53.00 target price for the company. Royal Bank Of Canada reissued a “buy” rating and set a $55.00 target price on shares of HealthSouth Corporation in a research note on Wednesday, September 6th. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a research note on Thursday, September 7th. Finally, Zacks Investment Research raised HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 target price for the company in a research note on Thursday, June 29th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. HealthSouth Corporation has a consensus rating of “Hold” and an average price target of $49.71.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.